| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 90 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 90 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 90 |
| 3 | FLUDARABINE PHOSPHATE | 60 |
| 4 | METHOTREXATE | 59 |
| 5 | METHOTREXATE SODIUM | 59 |
| 6 | ETOPOSIDE | 45 |
| 7 | DEXAMETHASONE | 41 |
| 8 | DEXAMETHASONE 1.5 MG | 41 |
| 9 | MYCOPHENOLATE MOFETIL | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARMUSTINE | 36 | 0.0076 |
| 1 | CHLORAMBUCIL | 16 | 0.0041 |
| 2 | PLERIXAFOR | 6 | 0.0040 |
| 3 | TREOSULFAN | 9 | 0.0033 |
| 4 | PALIFERMIN | 1 | 0.0026 |
| 5 | DANAZOL | 6 | 0.0021 |
| 6 | TAGRAXOFUSP | 1 | 0.0019 |
| 7 | IFOSFAMIDE FOR INJECTION | 39 | 0.0018 |
| 8 | BUSULFAN | 26 | 0.0016 |
| 9 | FLUDARABINE PHOSPHATE | 60 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 112 |
| 1 | Corticosteroid [EPC] | 59 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 59 |
| 3 | Topoisomerase Inhibitor [EPC] | 45 |
| 4 | Platinum-based Drug [EPC] | 41 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 40 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 37 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 35 |
| 8 | Leukocyte Growth Factor [EPC] | 23 |
| 9 | Thalidomide Analog [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hematopoietic Stem Cell Mobilizer [EPC] | 6 | 0.0040 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 3 | 0.0009 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 5 | Topoisomerase Inhibitor [EPC] | 45 | 0.0006 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 11 | 0.0006 |
| 7 | Alkylating Drug [EPC] | 112 | 0.0005 |
| 8 | CD30-directed Immunoconjugate [EPC] | 4 | 0.0004 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |